Mustang Bio, Inc.
MBIO
$1.16
-$0.04-3.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.58% | -398.04% | 83.93% | 32.48% | 82.80% |
| Total Depreciation and Amortization | -- | -100.00% | -45.33% | 47.06% | 5,000.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.07% | -436.43% | -106.70% | 472.73% | -146.75% |
| Change in Net Operating Assets | -85.63% | 115.30% | 64.59% | -2,069.94% | -96.50% |
| Cash from Operations | 38.91% | 3.60% | 30.45% | -13.66% | 24.75% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 36.93% | 448.52% | -80.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,140.43% | -103.09% | 54.29% | 386.79% | -80.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 501.97% | -121.29% | 151.51% | 495.56% | -125.35% |